Published in J Virol on December 01, 1994
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol (1997) 1.79
Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med (2007) 1.66
Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol (1998) 1.44
Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism. J Virol (1996) 1.43
Late expression of a beta chemokine homolog by murine cytomegalovirus. J Virol (1997) 1.39
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology (1997) 1.32
Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome. Virol J (2008) 1.12
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Current concepts: mouse models of Sjögren's syndrome. J Biomed Biotechnol (2010) 1.06
Murine cytomegalovirus encodes a stable intron that facilitates persistent replication in the mouse. Proc Natl Acad Sci U S A (2006) 1.04
Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis. Exp Mol Pathol (2011) 0.97
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread. PLoS Pathog (2015) 0.93
Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes. J Virol (2011) 0.93
In vitro and in vivo characterization of a murine cytomegalovirus with a transposon insertional mutation at open reading frame M43. J Virol (2000) 0.91
The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex. PLoS Pathog (2013) 0.88
Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome. Clin Rev Allergy Immunol (2012) 0.86
Murine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo. J Virol (2003) 0.85
Persistence of hAQP1 expression in human salivary gland cells following AdhAQP1 transduction is associated with a lack of methylation of hCMV promoter. Gene Ther (2015) 0.83
Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol (2011) 0.81
Comparison of the pathogenesis of the highly passaged MCMV Smith strain with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal inoculation. Vet Res (2015) 0.78
The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland. J Virol (2014) 0.77
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol (1988) 12.84
Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu Rev Biophys Biophys Chem (1986) 11.00
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol (1977) 3.07
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol (1992) 2.72
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol (1992) 2.08
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain). Virology (1983) 2.06
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Virulence and attenuation of murine cytomegalovirus. Infect Immun (1971) 2.03
Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Top Microbiol Immunol (1990) 2.00
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med (1956) 1.94
Translational control of human cytomegalovirus gp48 expression. J Virol (1991) 1.90
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch Virol (1979) 1.88
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Detection of human salivary gland virus in the mouth and urine of children. Am J Hyg (1958) 1.77
Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med (1954) 1.71
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection. Am J Pathol (1972) 1.48
Cytomegaloviruses of man and animals. Prog Med Virol (1973) 1.43
Structure and expression of murine cytomegalovirus immediate-early gene 2. J Virol (1991) 1.37
Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice. J Gen Virol (1992) 1.18
Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect Immun (1983) 1.09
Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus. J Med Microbiol (1979) 1.09
Identification of the glycoprotein H gene of murine cytomegalovirus. J Gen Virol (1992) 1.00
Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. Virology (1992) 0.91
Pathogenicity and immunogenicity of temperature-sensitive mutants of murine cytomegalovirus. J Gen Virol (1983) 0.87
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
Production of single-stranded plasmid DNA. Methods Enzymol (1987) 39.38
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. Proc Natl Acad Sci U S A (1980) 6.66
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell (1980) 4.47
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell (1982) 4.36
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J (1989) 3.58
Site-specific inversion sequence of the herpes simplex virus genome: domain and structural features. Proc Natl Acad Sci U S A (1981) 3.45
Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc Natl Acad Sci U S A (1982) 3.44
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci U S A (1989) 2.64
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol (1985) 2.46
Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med (1983) 2.36
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J Virol (1994) 2.34
Inferring parameters of mutation, selection and demography from patterns of synonymous site evolution in Drosophila. Genetics (2001) 2.29
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol (1979) 2.16
Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A (2001) 2.10
Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc Natl Acad Sci U S A (1992) 2.09
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
The pFF plasmids: cassettes utilising CaMV sequences for expression of foreign genes in plants. J Biotechnol (1990) 2.00
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology (2001) 1.85
Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis (1997) 1.84
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer (2009) 1.82
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
A method to identify distinctive charge configurations in protein sequences, with application to human herpesvirus polypeptides. J Mol Biol (1989) 1.75
A DNA helicase induced by herpes simplex virus type 1. Nucleic Acids Res (1988) 1.70
Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol (1993) 1.70
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis (1995) 1.69
Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology (1997) 1.66
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
Isolation and expression of cDNA clones encoding a human receptor for IgG (Fc gamma RII). J Exp Med (1987) 1.60
Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci (1999) 1.56
A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene. J Virol (1987) 1.55
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J Virol (1992) 1.52
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA. Virology (1988) 1.49
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
Nucleotide sequence and structural features of a novel US-a junction present in a defective herpes simplex virus genome. J Virol (1985) 1.44
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
Prenatal sonographic diagnosis of a rare Cantrell's pentalogy variant with associated open neural tube defect - a case report. Fetal Diagn Ther (2007) 1.43
Nucleotide sequence analysis of a zein genomic clone with a short open reading frame. Gene (1984) 1.42
A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma (2004) 1.42
cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma. Proc Natl Acad Sci U S A (1985) 1.41
Persistence of the cytomegalovirus genome in human cells. J Virol (1979) 1.39
Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl (1995) 1.37
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J Virol (1989) 1.36
Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis (1998) 1.35
Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood (1999) 1.33
Beam loading in the nonlinear regime of plasma-based acceleration. Phys Rev Lett (2008) 1.28
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J Virol (2001) 1.28
Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J Gen Virol (1987) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol (1999) 1.23
Membrane glycoproteins and antigens induced by human cytomegalovirus. J Gen Virol (1979) 1.23
Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis (1984) 1.22
Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression. J Gen Virol (1994) 1.21
Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence and latency. Curr Top Microbiol Immunol (1990) 1.19
Cloning and analysis of two new isoforms of multifunctional Ca2+/calmodulin-dependent protein kinase. Expression in multiple human tissues. J Biol Chem (1993) 1.16
Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol (1998) 1.15
Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci (2000) 1.10
Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology (1992) 1.09
Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. J Biol Chem (1992) 1.08
Circadian rhythms of nucleic acid metabolism in Neurospora crassa. J Bacteriol (1974) 1.07
Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol (2000) 1.07
Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res (1986) 1.05
Overweight and obesity in Portugal: national prevalence in 2003-2005. Obes Rev (2007) 1.04
The evolution of codon preferences in Drosophila: a maximum-likelihood approach to parameter estimation and hypothesis testing. J Mol Evol (1999) 1.04
Rodent IgE-binding factor genes are members of an endogenous, retrovirus-like gene family. J Immunol (1986) 1.03